The American Journal of Psychiatry has issued an Expression of Concern about a 2003 paper that was apparently simultaneously submitted to a German-language journal. According to the notice in the August 2011 issue of the journal (link added): Continue reading Duplicate submission from 2002 in American Journal of Psychiatry earns an Expression of Concern
Category: duplication retractions
India’s Kalasalingam University swiftly fires professor, kicks out six students after data manipulation scandal
Kalasalingam University in India has fired a professor who last month blamed unethical students for data manipulation that forced the retraction of three papers amid questions about five more.
As Krishna Pillai of the K2P blog reports, Sangiliyandi Gurunathan, head of Kalasalingam’s biotechnology department, was asked to resign, and did so on Friday, August 5. Kalasalingam also revoked the registrations of six graduate students who were co-authors on the retracted papers. Here’s the university press release with the details.
In comments to Retraction Watch for our earlier post, Gurunathan laid the blame on unethical students and journals, although his story didn’t quite hold together: Continue reading India’s Kalasalingam University swiftly fires professor, kicks out six students after data manipulation scandal
Another retraction for Milena Penkowa, this one in Experimental Physiology
There’s another retraction in the the complicated case of Milena Penkowa, the former University of Copenhagen researcher being investigated for scientific misconduct and misuse of grant funds. The paper, in Experimental Physiology, was titled “Exercise-induced metallothionein expression in human skeletal muscle fibres” and was published online in January 2005.
It’s the second retraction for Penkowa, who did not sign either of them. According to the notice: Continue reading Another retraction for Milena Penkowa, this one in Experimental Physiology
Physics paper retracted “on ethical grounds” — aka the data had already been published
There was a curious retraction published online last month in Physica Scripta, an Institute of Physics journal. The notice, for “Response of Cu 0.5 (Tl 0.5-y Hg y)Ba 2 Ca 3 Zn 2 Cu 2 O 12-δ (y =0, 0.15, 0.25 and 0.35) superconductors in electric and magnetic fields,” reads as follows: Continue reading Physics paper retracted “on ethical grounds” — aka the data had already been published
Should we change our name to Mori Watch? Yet another retraction from cancer researcher
Earlier this week we reported on the latest retraction of an article by Naoki Mori, number 21 in a series. We could have waited a few days and saved ourselves some trouble.
The journal Leukemia Research has retracted a 2006 paper by Mori, titled “Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.” From the notice, which is behind a paywall: Continue reading Should we change our name to Mori Watch? Yet another retraction from cancer researcher
Second retraction by Harvard group studying cannabinoids, this one in JBC
Last week, we reported that a group of Harvard researchers had retracted a paper in Blood for “multiple instances of duplicate (redundant) publication of data, text, and images that are nonessential to the paper.” The retraction notice referred to a paper in the Journal of Biological Chemistry (JBC):
The redundancies are between the above-cited Blood article and the following 12 November 2010 article, published in the Journal of Biological Chemistry (JBC): Jiang S, Zagozdzon R, Jorda MA, et al. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment. J Biol Chem. 2010;285(46):35471-35478.
Today, we learned that the JBC paper has also been retracted. The notice, as we’ve come to expect from the JBC, is unhelpful: Continue reading Second retraction by Harvard group studying cannabinoids, this one in JBC
Four mysterious retractions in the JBC for a group whose PI recently passed away
The Journal of Biological Chemistry (JBC) has retracted four studies done in a Mount Sinai School of Medicine lab whose principal investigator died last month. The studies, by the late Maria Diverse-Pierluissi and colleagues, were as follows:
- N-type Ca2+ channels as scaffold proteins in the assembly of signaling molecules for GABA-B receptor effects (cited 9 times, according to Thomson Scientific’s Web of Knowledge)
- Arrestin is required for agonist-induced trafficking of voltage-dependent calcium channels (cited 15 times)
- G protein-induced trafficking of voltage-dependent calcium channels (cited 34 times)
- B-Adrenergic receptor activation induces internalization of cardiac Cav1.2 channel complexes through a B-arrestin 1-mediated pathway (cited 8 times)
According to a Mount Sinai release, Diverse-Pierluissi died on May 7 of this year. The retractions are dated June 17, and all say the same thing: Continue reading Four mysterious retractions in the JBC for a group whose PI recently passed away
“Nonessential” duplication leads to retraction of Blood cannabinoid paper
The journal Blood has retracted a paper from a group of prestigious Harvard researchers after the article, which appeared in January 2011, was found to have multiple instances of material — text, data and other elements — that had appeared in a previous publication from several of the authors.
The article was titled “Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.” Its authors included Hava Avraham, a noted cancer researcher, and Jerome Groopman, known for his New Yorker articles about medicine and, scientifically, for his work on cannabinoids and cancer, among other areas.
According to the retraction notice: Continue reading “Nonessential” duplication leads to retraction of Blood cannabinoid paper
The new math: How to up your citations (hint: duplication). Plus a correction for Naoki Mori
Here’s a good way to increase the number of times your work is cited: Publish studies three times.
On second (or third) thought, maybe not: The Journal of Steroid Biochemistry & Molecular Biology has retracted a pair of articles by three Japanese researchers who apparently liked their own work so much they decided to submit it, and submit it—and submit it again.
Here’s the notice for the first paper, a 2004 publication titled “Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex,” by Shigeaki Kato, Ryoji Fujiki and Hirochika Kitagawa, fairly well-known molecular endocrinologists at the University of Tokyo: Continue reading The new math: How to up your citations (hint: duplication). Plus a correction for Naoki Mori
Retractions we haven’t had a chance to cover, part 3: Another duplication and plagiarism edition
As more and more journals enroll in CrossCheck, designed to ferret out cases of plagiarism, it’s to be expected that the number of papers retracted for copying and pasting will increase. Sometimes, that plagiarism is actually duplication of material that the same authors have published elsewhere, while other times it’s good old-fashioned plagiarism of someone else’s work, as these five notices in our latest edition of “Retractions we haven’t had a chance to cover” suggest:
1. Journal of Minimal Access Surgery: When the editor of a journal where you’ve published sends you an email, it’s a good idea to reply. A retraction notice in the April-May issue: Continue reading Retractions we haven’t had a chance to cover, part 3: Another duplication and plagiarism edition